P-postlabeling assay for 7-alkyl-2'-deoxyguanosines, adducts were measured in eight separate lung segments of ten autopsy donors. 7-Methyl-dGp levels were detected in all eighty samples (range from 03 to 11.5 adducts/10 7 dGp,-mean 2.5 ± 23 adducts/10 7 dGp). 7-Ethyl-dGp were detected in all but five of the samples (range from <0.1 to 7.1 adducts/10 7 dGp; mean 1.6 ± 1.7 adducts/10 7 dGp). 7-Methyl-dGp levels were approximately 1.5-fold higher than 7-ethyl-dGp levels, and they were positively correlated with each other in most individuals. There was no consistent pattern of adduct distribution in the different lobar segments. Most individuals, especially those with the lowest levels, had similar levels among the lobes, while those with the highest levels had a widely variable pattern ranging as much as ten-fold. Moreover, 7-methyl-dGp and 7-ethyl-dGp levels in all people showed a highly significant inter-individual variation (P = 0.0001). The levels of 7-alkyl-2'-deoxyguanosine among individuals could not be explained by differences in tobacco exposure (measured by serum cotinine), onset of death, gender, age, race, blood ethanol, or ventilation and perfusion variability. In an effort to corroborate 7-alkyl-2'-deoxyguanosine adducts variability among lobes or individuals, we sought to determine a correlation with HPB-releasing DNA
Introduction
Levels of carcinogen-DNA adducts reflect both carcinogen exposure, the host's ability to metabolically activate and detoxify carcinogens, and repair DNA (1) . Some adducts are promutagenic and associated in experimental studies with carcinogenesis (2, 3) . Several studies have measured carcinogen-DNA adducts in lung tissue (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . If levels vary in different parts of an organ, then misclassification of individuals might lead to the false estimation of cancer risk. Also levels of DNA adducts in different parts of the lung might be associated with cancer incidence in that part.
Alkylating agents such as N-nitroso compounds are potential human carcinogens. Humans are exposed to /V-nitrosamines in the diet (19) , in the workplace (20), through endogenous formation (21, 22) and from cigarette smoke (20). These compounds alkylate DNA leading to promutagenic lesions such as G^ethyW-deoxyguanosine (G^methyl-dG*) (23) , but the low levels of this adduct in human tissues challenge many existing assays. However, 7-alkyl-2'-deoxyguanosine adducts [e.g. 7-methyl-2'-deoxyguanosine-3'-monophosphate (7-methyl-dGp) and 7-ethyl-2'-deoxyguanosine-3'-monophosphate (7-ethyl-dGp)], although not promutagenic, are predominant alkylation products and are plausibly used as surrogate markers for G^methyl-dG and other promutagenic alkylated bases.
Tobacco smoke, the primary cause of lung cancer, contains several types of N-nitrosamines. The most abundant of these are the tobacco specific nitrosamines, including the lung specific carcinogen 4-(methylnitrosamino)-1 -(3-pyridyl)-1 -butanone (NNK) (24) . These and other compounds such as small amounts of N-nitrosodimethylamine (NDMA) and Nnitrosodiethylamine (NDEA) are metabolically activated to reactive species which form DNA adducts (23, 25, 26) . NDMA and NDEA have been shown to be metabolically activated by human bronchial explants to form methylated and ethylated bases, respectively (27) (28) (29) . NNK both methylates and pyridyloxobutylates DNA, generating 0 6 methyl-2'-deoxyguanosine (C^methyl-dG), 7-methyl-dGp (30, 31) and adducts which release 4-hydroxy-(3-pyridyl)-l-butanone (HPB) upon acid hydrolysis (26) . The latter group of adducts are specific for the nicotine derived nitrosamines NNN and NNK. NNK is a potent respiratory tract carcinogen in animals (25) , causes transformation of human bronchial epithelial cells (32) , and the HPB-releasing adduct has been detected in DNA isolated from the lungs of smokers (7) .
If carcinogen-DNA adducts are related to lung cancer risk, then their distribution in lung tissue might be associated with the lobar incidences of lung cancer. It has been previously reported (33) (34) (35) (36) that among 15 477 cases of lung cancer, 65.2% occurred in the upper lobes, 6.3% in the middle lobes, and 28.5% in the lower lobes (36) . The incidence also is dependent upon the histological type and smoking status of the patients (37) . Among nonsmokers and former smokers, a decreased incidence of central bronchogenic cancers and an increase of peripheral lung adenocarcinoma have been observed. Peripheral tumors have increased from 31% before 1978 to 42% from 1986 to 1989.
To date, several investigations (8, 10, 12) have focused on the levels of 7-methyl-dGp adducts in human lungs. Higher levels have been found in smokers compared to nonsmokers (8) . Separately, 7-methyl-dGp levels in lung tissues have been associated with cytochrome P450 IID6 and HE] genetic polymorphisms (38) . Currently, there are no similar published studies for 7-ethyl-dGp. We present herein a study of 7-methyldGp and 7-ethyl-dGp adduct distribution in human lung of ten autopsy donors. The present study investigates the lobar distribution of several TV-nitrosamine-related DNA adducts in order to elucidate associations with cancer incidence, and validate the use of random carcinogen-DNA adduct analysis as a representative marker of adduct levels throughout the lung.
Materials and methods

Tissue collection
Lung samples were obtained from autopsy donors (n = 10) within 12 hours following death. Donors were from a Baltimore, Maryland medical examiner's office. All individuals were free of cancer. Age range ( 27 to 68 years); gender (three females and seven males); race (four African-Americans and six Caucasians); and blood ethanol levels were determined by the medical examiner. Tissue samples from eight parts of the lung were collected and flash frozen in liquid nitrogen. The lobar and segmental location of the parts are shown in Figure I . These sections herein are referred to as the right superior lobe, apical segment (Rl); right superior lobe, anterior segment (R2); right inferior lobe, medial basal segment (R3); right inferior lobe, posterior basal segment (R4); left superior lobe, apical segment (LI); left superior lobe, lingular segment (L2); left inferior lobe, medial basaJ segment (L3): and left inferior lobe, posterior basaJ segment (L4). DNA from the tissues was extracted as previously described (39) .
Serum cotinine analysis
Serum cotinine levels were determined using a radioimmunoassay with polyclonal antibodies as previously described (40) . 7-Alkyl-deoxyguanosine adduct analyses 7-Methyl-dGp and 7-ethyl-dGp were purified by two sequential HPLC steps and quantitated by the * 2 P-postlabeling assay (10) . All syntheses of adduct standards were performed exactly as previously described (10, 12) . The method was found to be chemically-specific and was validated using synthesized radiolabeled standards; detection limits and adduct recoveries were previously reported (10) and the overall adduct recovery with this method was 58% for 7-methyl-dGp and 98% for 7-ethyl-dGp. Briefly, DNA was digested to nucleoside-3'-monophosphates with micrococcal nuclease (5 units; Sigma, St Louis; MO) in the presence of reaction buffer (20 |il, 25 mM Tris-HCI. 25 inM CaCl 2 , pH 8.8, 37°C, 30 min), followed by calf spleen phosphodiesterase (20 (il, 2 mg/ml, 90 min). The DNA digest was subjected to an initial HPLC purification (ion-pair reverse phase). The fractions containing the adducts were dried in vacuo and subjected to a second HPLC purification step (weak anion exchange). Fractions containing the adducts were dried in vacuo and analyzed by the 32 MgClj, pH 9.5) and T4 polynucleotide kinase (DuPont NEN, Wilmington, DE), (10 units; 37°C, 45 min). A second aliquot of T4 polynucleotide kinase (10 units) was added for a further incubation period (45 min). The reaction mixture (7 |il) was resolved by 2-dimensional thin layer chromatography (polyethyleneimine cellulose thin layer chromatography plates, 2OX2Ocm , Macherey-Nagel, Germany) and adducts were identified by co-elution with non-radioactive standards. Nucleotides were visualized and quantitated on the chromatography plates by a radioanalytical image detection system (Ambis, San Diego, CA). A molar ratio of radiolabeled p7-methyl-dGp or p7-ethyldGp to pdGp was calculated and extrapolated back to the amount of dGp in the sample Each sample was analyzed twice. All lobes from an individual were analyzed together in a single batch; the replicate was performed several weeks later. Within every set of 16 samples, one DNA sample with a known adduct level was analyzed as a control.
4-Hydroxy-(3-pyridyl)-1-butanone (HPB) releasing adduct analysis
was hydrolyzed in 0.1 N NaOH at 80°C for 3 h as previously described (7, 41) . Following neutralization, HPB and D 2 -HPB were extracted, derivatized, further purified and analyzed by GC-MS with detection by select ion monitoring with negative ion chemical lonization.
Venlilation/perfusion lung scans
Lung scan data from seven normal volunteer subjects (unrelated to the autopsy donors who were studied for adduct analysis) were reviewed in order to assess perfusion and ventilation variability among different lobes. Lung scans were performed as previously reported (42) . No subject had a history of significant medical problems such as asthma, pneumonia or pulmonary emboli. Ventilation scans were performed using approximately 15 mCi of l33 Xe. For the perfusion studies, 2 mCi of "TC-MAA were used intravenously. Imaging was performed with a scintillation camera. The analysis was done on posterior images using four regions of interest in each lung from apex to base.
Statistical methods
Spearman's correlation coefficients were determined for the analysis of adduct levels in different lobes (Statistica. StatSoft, Tulsa, OK). Wikroxon scores (Rank sums) tests were applied for determination of differences between adduct levels and lobes (Statistical Analysis System, Cary, NC) The Pearson correlation coefficient was used to assess the correlation between duplicate adduct analyses. Multivanate analysis of variance for repeated measures was used to assess the influence of assay variability on adduct levels. General multi-linear regression was used to assess the dependence of adduct levels on location (lobe) and intenndividual variation as independent variables (Proc GLM; Statistical Analysis Systems, Cary, NC).
Results
Subject-study characteristics and 7-alkyl-dGp levels are summarized in Table I . In individuals, the total mean of 7-methyldGp levels varied between 0.7 and 5.0 adducts/10 7 dGp. Mean 7-ethyl-dGp levels ranged between 0.9 and 3.6 adducts/10 7 dGp. No striking relationship was found between adduct levels and gender, age, race, serum cotinine or blood ethanol, although the small study set excluded a meaningful statistical analysis. As a consequence no statistical analysis was performed. The cause of death also did not appear to be related to adduct levels. Based upon serum cotinine, individuals can generally be classified as active smokers (>80 ng/ml) versus nonsmokers, who were possibly passive smoke exposed individuals or individuals who did not smoke within the last 72 h (43). Overall, 7-methyl-dGp and 7-ethyl-dGp were positively correlated (r = 0.539, P = 0.0001), but this was attributed to only six (cases 2708, 2908, 2856, 2686, 2878, 2749) of the ten individuals studied. The ratio of 7-methyl-dGp to 7-ethyl-dGp for all individuals and all segments combined was 1.5, ranging in individuals from 0.8 to 6.0.
7-Methyl-dGp was detected in all 80 lobar segments ( Figure 2 ). 7-Ethyl-dGp adducts were detected in all but 5 of the 80 segments of the ten individuals. Analyses were done in duplicate and the assay was reproducible (Figure 3) . The correlation coefficients for the blinded duplicate analyses performed on different days were 0.723 for 7-methyl-dGp (n = 80; P = < 0.01) and 0.685 for the 7-ethyl-dGp (n = 75; P = < 0.01). There was no consistent pattern of adduct distribution among the lobar segments (Tables II and HI Methyl-dGp levels ranged from 0.3 to 11.5 adducts/10 7 dGp (mean: 2.5 ± 2.3 adducts/10 7 dGp), 7-ethyl-dGp levels ranged from <0.1 to 7.1 adducts/10 7 dGp (mean: 1.6 ± 1.7 adducts/ 10 7 dGp). Repeated measure analysis excluded assay variability as a likely explanation for the within-subject variability (interindividual variation) or within-individual variability (lack of specific 7-alkyl-dGp pattern). There was no statistical significance for a time effect (P = 0.82 and P = 0.50 for 7-methyldGp and 7-ethyl-dGp, respectively), or for interaction of time and lobe (P = 0.39 and P = 0.27 for 7-methyl-dGp and 7-ethyl-dGp, respectively) or time and individual (P = 0.35 and P = 0.81 for 7-methyl-dGp and 7-ethyl-dGp, respectively). Accounting for repeated measures, lobar segment location was still not statistically significant (P = 0.29 and P = 0.41 for 7-methyl-dGp and 7-ethyl-dGp, respectively), but the individual subject was (P = 0.0001 for 7-methyl-dGp and 7-ethyl-dGp).
For seven of the ten individuals, the 7-methyl-dGp and 7-ethyl-dGp level in a segment was similar to levels in other segments, considering the assay-related variability (Figure 3) . These individuals had lower adduct levels. For the other three individuals (cases 2778, 2683, 2708) the levels ranged from 10-fold and 13-fold for 7-methyl-dGp and 7-ethyl-dGp, respectively. There was no distinct pattern for upper versus lower lobes (7-methyl-dGp mean, 2.3 versus 2.7, P = 0.76; 7-ethyldGp mean, 1.7 versus 1.5, P = 0.99 respectively); central versus peripheral segments (7-methyl-dGp mean, 2.4 versus 2.6, P = 0.64; 7-ethyl-dGp mean, 1.5 versus 1.8, P = 0.31 respectively); or right versus left lobes (7-methyl-dGp mean, 2.4 versus 2.7, P = 0.23; 7-ethyl-dGp mean, 1.5 versus 1.8, P = 0.45 respectively). The inter-individual variation in adduct levels was greater than intra-organ variation. Figure 4 shows the inter-individual variation of the adduct levels for all ten subjects. Multi-linear regression for 7-methyl-dGp or 7-ethyl-dGp levels, where lobe and individuals (by identification numbers) were entered as categorical independent variables, indicated that only the individual status was highly associated with adduct levels. In the model for 7-methyl-dGp, the overall correlation coefficient was r 2 = 0.51 (f = 4.17, P < 0.0001) and the P-value for individuals was < 0.0001 and for the lobes the P-value was 0.12. For 7-ethyl-dGp the overall correlation coefficient was r 2 = 0.53 if = 4.53, P < 0.0001), and the P-value for individuals was < 0.0001 and for the lobes the P-value was 0.14.
In an attempt to explore the wide intra-organ variation in adduct levels among some persons, we reviewed data of an unrelated set of seven normal volunteers who underwent radionuclide ventilation and perfusion scanning. Because the results of this procedure are highly dependent on body size and the force of gravity, we tested whether there was wide intra-organ variation for right versus left side of lungs (Table  IV) . No variation was found for either ventilation or perfusion, in contrast to levels of 7-alkyl-dGp. Therefore, the observed right versus left side of lung heterogeneity for adduct levels in some persons is not likely to be based on individual ventilation and perfusion variabilities. DNA samples from all eight lobar segments from cases 2778, 2708, 2719 and 2749 were analyzed for the HPBreleasing adduct (representative of exposure to NNN and NNK). No adducts were detected. The limit of detection ranged from 8 to 50 fmol HPB/mg DNA (or >0.3 adducts/10 7 dGp) depending on the amount of DNA analyzed.
Discussion
The results of this study indicate that 7-methyl-dGp and 7-ethyl-dGp adducts are not distributed throughout human lungs with a specific pattern. The methodology for detection was previously validated and chemically specific. The use of autopsy donors who died of sudden death allowed for an in vivo examination of adduct levels in persons whose behavior was unlikely to have been modified by disease or other factors associated with death. Individuals could be classified as having overall high, medium or low adduct levels. The results indicate that for most individuals, a random lung sample would be representative of levels throughout their lungs. However, because 30% had widely varying 7-alkyl-DNA adduct levels, a molecular epidemiology study of adduct levels in lung tissue might misclassify adduct burden of some individuals, if only one segment or lobe is studied. Misclassification would lead to loss of statistical power. Thus, large studies of individuals or sampling from multiple parts of the lung is recommended for molecular epidemiology studies of human lung tissues. In the future, measurements in specific cell types would be required because of the possibility that given the heterogeneity of cell types in the lung even multilobe measurements could lead to misclassification of exposure status.
The combined HPLC and 32 P-postlabeling assay for the measurement of 7-methyl-dGp and 7-ethyl-dGp is a sensitive and specific procedure that has been previously validated by multiple corroborative endpoints, including the use of radiolabeled standards and several detection methods (10, 12) . In this study, blinded duplicates of 80 samples provided a reasonably high correlation coefficient. In individuals, the mean adduct levels in peripheral lung DNA were found to range from 0.7 to 5.0 7-methyl-dGp adducts per 10 7 dGp, and for 7-ethyl-dGp from 0.9 to 3.6 adducts per 10 7 dGp. These levels are in concordance with our previously reported results (10) , and other groups have reported similar values for 7-methyl-dGp in bronchi of nonsmoking individuals (8) . The 7-alkyl-dGp adducts in human lung tissues likely result from exogenous N-nitrosamine exposures such as N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine (NDEA), 4-(methylnitrosoamino)-l-(3-pyridyl)-l-butanone (NNK) in tobacco (44) and possibly dietary intake (45) . Endogenous methylation also might contribute to adduct levels, but only in small amounts. For example, S-adenosylmethionine (SAM) can non-enzymatically methylate DNA (46, 47) as suggested by in vitro studies. However, the 7-alkyl-dGp levels in human lung in vivo are substantially higher than reported for SAM studies (46) . One previous investigation (47) reported higher levels but this in vitro study used non-physiologically high amounts of SAM.
The data reported herein show a highly significant interindividual variation for 7-alkyl-dGp adduct levels between people, which is most likely related to individual differences in carcinogen metabolism and for DNA repair (48, 49) . In particular, cytochrome P450I1E1 (CYPIIEl) activates carcinogenic N-nitrosamines and other low-molecular-weight compounds (50) . Genetic polymorphisms in this gene have been associated with differences in 7-methyl-dGp levels in human lungs (38) . Separately, it is known that CYPIIEl is induced by ethanol; but in this small sample set, higher adduct levels were not found in people with elevated blood ethanol levels. While the CYPIIEl protein is present in human lungs in small quantities (51) , the relationship between enzyme quantity and activity for adduct formation in humans needs further study.
The inter-individual variation could not be explained grossly by differences in gender, age, race, serum cotinine or blood alcohol levels. The variations however, may still be due to exposure rather than heritable capacity for methylation (i.e. metabolic activation of dietary Af-nitrosamines). Because personal interviews were not possible, the actual individual exposures remain unknown. Second, cotinine and blood alcohol levels are not the best predictor for chronic tobacco and alcohol use. Although, for tobacco exposure in these donors, serum cotinine was likely to be a good indicator of recent tobacco use. Despite the fact that it has a short half-life, most of the persons were unlikely to have modified their smoking habits prior to their sudden and unexpected death.
To corroborate the lack of relationship to tobacco use, we attempted to measure the HPB-releasing adduct, which specifically reflects exposure and activation of either NNN or NNK. In the four subjects analyzed, no such adducts were detected. We expected to see this adduct in two of the four cases because they were classified as active smokers by their serum cotinine levels. In these two individuals 7-methyl-dGp levels were between 0.3 and 4.7 adducts/10 7 dGp (mean: 1.5 7-methyl-dGp/10 7 dGp). The average detection limit for the HPB-releasing adduct was 0.3 adducts/10 7 dGp 7-methyl-dGp in these samples. Knowing that in NNK treated rats, the ratio of methylation to pyridyloxobutylation varies between 7.5 and 25 (52) and assuming that a similar relationship exists in smokers exposed to NNK, is it not surprising that no HPBreleasing adducts were found in these samples, given the level of methylation detected. In addition, as noted, there are other sources of 7-methyl-dGp in addition to NNK.
The intra-individual variation in adduct levels among lobes was high for some individuals. However, no consistent pattern of adduct distribution was found. One possible explanation to consider would be assay variability. We do believe that our study design of multiple testing, the correlation of the replicates (which were performed on different days) and multiple comparison procedures make assay variability an unlikely explanation for the results.
We explored several possibilities for the random distribution of 7-alkyl-dGp levels across lobes. Alkylating agents reach the lung through inhaled air (i.e. tobacco smoke), blood (i.e. dietary intake) or both. To explore these potential variations, we reviewed ventilation and perfusion scan data from seven unrelated individuals. Using these radionuclide scanning studies, neither ventilation nor perfusion displayed intra-organ or inter-individual variation. Thus, although nuclear medicine studies may not be equivalent to assessing paniculate or tobacco gas flow in lung airways, it is unlikely that the lack of consistency across individuals was due to differences in air or blood flow. Alternatively, intra-organ variation of the 7-alkyl-dGp levels could be explained by different cell types in different lobar segments. There are over 40 cell types found in human lungs (53) with different capacities to activate carcinogens. Non-ciliated (Clara) cells, which are present throughout the airways and at the site of most human pulmonary carcinomas (54) , have a considerably lower capacity to repair DNA damage relative to alveolar type II cells in vitro (55) . In the rat, NNK is most efficiently metabolized by Clara cells (56) , and when NNK is administered to rats, the highest level of both DNA methylation and pyridyloxobutylation occurs here (57, 58) . Further, differential metabolic activation or detoxification of alkylating agents in different lung segments, due to different concentrations of cells, is also possibly responsible for the observed variance of DNA-adduct levels. However, the expression of activating cytochrome P450s, for example, has never been reported in different parts of human lungs, so the origin of this intra-organ variation remains unknown.
For all samples, 7-methyl-dGp levels were approximately 1.5-fold higher than 7-ethyl-dGp levels. The ratio for individuals, however, varied from 0.8 to 6.0. The different ratios could be related to differences in exposure [i.e. NDMA, NDEA and NNK in tobacco (44) ] or differential metabolic activation (59), detoxification and repair capacities. Laboratory animal studies have found that alkylation in mouse liver produced 8.0 pmol 7-methylG/g DNA versus 1.2 pmol 7-ethylG/g DNA for equimolar amounts of NDMA and NDEA, respectively (60) . This difference is likely to be due to metabolic capacity. In human cells, cytochrome P450s are known to activate these compounds differently; transfected human B lymphoblastoid cell lines (61) expressing CYPIIE1 were 100-to 200-fold more sensitive to mutagenic effects of NDMA, while cells expressing cytochrome P450 IIA3 were more sensitive to NDEA.
In humans, each of the three major histological types of lung cancer occurs more commonly in the upper lobes (65.2%) versus the lower lobes (28.5%) (36, 37) . This study did not find an adduct pattern consistent with reported lobar cancer incidence (i.e. more adducts in the upper lobes than in the lower lobes). However, the small number of individuals studied in this report reduces its power to identify an association. It still may be that these adducts are related to cancer risk, but just not in all people, or that higher levels in specific lobar segments reflect a susceptibility in that segment of an individual's lung.
This study indicates the importance of intra-organ and interindividual variation when examining human lung tissues. Additional studies are needed to better assess exposures and to explore the inter-individual and intra-organ variation for cytochrome P450 expression and activity.
